Skip to main content
OpenTrials
Completed

NCT Number: NCT02020148

Can Oxytocin Level Predict Postpartum Depression?

The goal of this research study is to understand the relationship between the hormone oxytocin and postpartum mood.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Postpartum depression (PPD) affects some one in five new mothers, and adversely influences maternal adaptation to motherhood. While it is known that women with a prior history of depression, or depression during pregnancy, are at elevated risk for postpartum depression, many women with no prior history of depression or other risk factors go on to develop depression in the postpartum period. Considering the grave consequences of postpartum depression on maternal infant bonding and childhood psychological development, it is critical to develop reliable methods to identify which women, who are not depressed during pregnancy, will become depressed after delivery.

The biological pathways leading to depression at any time in life, including around pregnancy, are still poorly characterized. Oxytocin (OT), a hormone involved in delivery and lactation, has received recent attention regarding its additional role in maternal emotions and care taking behaviors after birth. The primary goal is explore the relationship between plasma oxytocin and postpartum mood.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years of age
  • English-speaking
  • Pregnant (third trimester at time of visit)

Exclusion criteria

  • Current active depression or other mental illness at time of study entry in the third trimester (past depression or anxiety is acceptable)
  • Current antidepressant treatment
  • Severe medical complications in current pregnancy (gestational diabetes, hypertension, thyroid disease)
  • Signs of multiple gestation or of fetal malformation in current pregnancy
  • Cigarette smoking beyond 10th week of gestation of current pregnancy
  • Pre-pregnancy BMI > 32

Treatment and study plan

Primary outcomes

  1. Inventory of Depressive Symptomatology, Self-Report (IDS-SR-30)

    Time frame: 4-6 weeks post delivery

    The IDS-SR-30 is a validated, widely used tool to evaluate depressive symptoms and clinical depression. Participants will complete this questionnaire in person or through telephone interview.

Sponsors and collaborators

Lead sponsor

Northwestern University

Other

Collaborators

  • Northwestern Memorial Hospital

Registry information

Official study title

Can Prenatal Plasma Oxytocin Concentration Predict Likelihood of Postpartum Depression? An Opportunity for Early Intervention and Prevention in a Vulnerable Population

Important dates

Study start
2013
Primary completion
2015
Study completion
2015
First posted
Dec 24, 2013
Registry last updated
Oct 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.